Phillip Coffin, MD

Photo of Phillip Coffin, MD
Title(s)Volunteer Associate Clinical Professor, Medicine
SchoolSchool of Medicine
Address1001 Potrero Avenue, #3421
San Francisco CA 94110
ORCID ORCID Icon0000-0002-3891-6570 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr Coffin is an internist, infectious disease, and addiction medicine specialist. He directs the Center on Substance Use and Health at the San Francisco Department of Public Health, focusing on developing medications to treat substance use disorders, as well as understanding and responding to opioid overdose and other drug toxicities, and training clinical care teams in management of substance use.

    Collapse Biography 
    Collapse education and training
    Brown University, ProvidenceBA05/1995Pssychology
    Columbia University, New YorkMIA05/2000International Affairs
    UCSF, San FranciscoMD05/2006Medicine
    Collapse awards and honors
    Heluna Health2025Award for Supporting People Affected by Substance Use
    Association for Multidisciplinary Education and Research in Substance Use and Addiction2024Anderson Spickard, Jr. Excellence in Mentorship Award
    Annals of Internal Medicine2012  - 2024Top Reviewer
    Summit Medical Center2021President's Award
    American Sociological Association2020Distinguished Scholarly Paper Award
    Infectious Disease Society of America2018Fellow
    American College of Physicians2016Fellow
    College on Problems of Drug Dependence2014Early Career Investigator Travel Award
    Annals of Internal Medicine2014Junior Investigator Recognition Award
    San Francisco Department of Public Health2013Public Health Recognition Award
    University of Washington2011Walter E. Stamm MD Award
    Seattle Metropolitan Magazine2011Top Doctor

    Collapse Research 
    Collapse Featured Publications
    Collapse research activities and funding
    Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
    NIH UG3DA066252Aug 1, 2026 - Jul 31, 2028
    Role: Co-Investigator
    Behavioral Safety and Fentanyl Education: BSAFE
    NIH R01DA064340Sep 30, 2025 - May 31, 2030
    Role: Principal Investigator
    Glutide for Ending Methamphetamine
    NIH UG3DA063329Sep 1, 2025 - Aug 31, 2027
    Role: Principal Investigator
    Leveraging Psychological Autopsies to Accelerate Research into Stimulant Overdose Mortality
    NIH R01CE003364Sep 30, 2021 - Sep 29, 2024
    Role: Principal Investigator
    PRIME: PrEP Intervention for people who Inject MEthamphetamine
    NIH R01DA051850Aug 1, 2020 - Jun 30, 2025
    Role: Principal Investigator
    Mirtazapine for methamphetamine use disorder: drug-drug interaction study
    NIH U01DA051080Jun 1, 2020 - May 31, 2022
    Role: Principal Investigator
    Repeated-dose behavioral intervention to reduce opioid overdose: a two-site randomized-controlled efficacy trial
    NIH R01DA045690Jun 15, 2018 - Mar 31, 2024
    Role: Principal Investigator
    The Summer HIV/AIDS Research Program (SHARP)
    NIH R25DA043441May 1, 2017 - Mar 31, 2028
    Role: Co-Investigator
    Midcareer K24 Award for Mentoring and Patient-Oriented Research
    NIH K24DA042720Sep 1, 2016 - Jan 31, 2028
    Role: Principal Investigator
    Substance use outcomes of opioid dose reduction and discontinuation
    NIH U01CE002793Sep 1, 2016 - Aug 31, 2018
    Role: Principal Investigator
    Cohort Study of Opioids, Pain, and Safety in an era of Changing Policy (COPING)
    NIH R01DA040189Aug 15, 2016 - May 31, 2021
    Role: Principal Investigator
    Hepatitis C Treatment As Prevention Pilot Study with Ledipasvir-Sofosbuvir Among People Actively Injecting Drugs (TasP-C Pilot)
    NIH R34DA039333Jul 15, 2015 - May 31, 2019
    Role: Principal Investigator
    An Assessment of Opioid Overdoses in San Francisco from 2010 through 2012
    NIH R03DA038084Jul 1, 2014 - Jun 30, 2017
    Role: Principal Investigator
    Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Nalo
    NIH R34DA037194Apr 1, 2014 - Mar 31, 2018
    Role: Principal Investigator
    Naloxone prescription for Opioid Safety Evaluation (NOSE)
    NIH R21DA036776Jul 15, 2013 - Jun 30, 2016
    Role: Principal Investigator
    Mirtazapine for the treatment of methamphetamine dependence among MSM with high-r
    NIH R01DA034527Feb 1, 2013 - Jan 31, 2019
    Role: Principal Investigator
    Naltrexone for the treatment of Actively-Using Met-Dependent MSM with High-Risk B
    NIH R01DA031678Jun 1, 2011 - Jul 31, 2017
    Role: Principal Investigator
    Reducing HIV risk among episodic substance-using MSM
    NIH UR6PS000684Sep 30, 2007 - Sep 29, 2013
    Role: Principal Investigator
    Aripiprazole to reduce methamphetamine use among MSM with high-risk HIV behaviors
    NIH R01DA023387Sep 28, 2007 - Jan 31, 2013
    Role: Principal Investigator
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Collaboration Interests
    Collapse Mentoring

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Provider Perspectives on the Delivery of Long-Acting PrEP for HIV Prevention to Men Who Have Sex with Men and Who Use Methamphetamine. AIDS Patient Care STDS. 2026 Aug 05; 10872914261474992. McMahan VM, Pope E, Luna Marti X, Liu AY, Coffin PO. PMID: 42552859.
      View in: PubMed   Mentions:    Fields:    
    2. Stimulant Use After Loss of Access to Prescribed Opioids for Chronic Noncancer Pain. Am J Prev Med. 2026 May 28; 71(4):108437. Suen LW, Chang YG, McMahan VM, Beliveau CM, Arenander J, Chiang A, Coffin PO. PMID: 42314278; PMCID: PMC13280283.
      View in: PubMed   Mentions:    Fields:    
    3. Qualitative study of bubble pack use during buprenorphine low dose initiation. J Am Pharm Assoc (2003). 2026 May 05; 103130. Parizher J, Panigrahi A, Geier M, Soran CS, Snyder HR, Knight K, Coffin PO, Suen LW. PMID: 42097485.
      View in: PubMed   Mentions:    Fields:    
    4. Integrating HIV and Stimulant-Use Disorder Treatment: A Pilot Implementation Effectiveness Trial of Contingency Management in HIV Care. Clin Infect Dis. 2026 Apr 30; 82(4):e728-e734. Appa A, Steiner G, Baral S, Riley E, Suchman L, Roberts K, Knight K, Murphy M, Chamie G, Shoptaw S, Coffin PO, Gandhi M. PMID: 41505433; PMCID: PMC13131947.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. The Contribution of Homelessness to Opioid Overdose Mortality and Associated Racial Disparities. J Urban Health. 2026 Apr; 103(2):304-308. Anderson N, McMahan VM, Tomashevsky I, Hom JK, Coffin PO. PMID: 42043455; PMCID: PMC13235676.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. A comparison of opioid overdose risk behaviors by race and ethnicity among overdose survivors in Boston, MA, and San Francisco, CA. Harm Reduct J. 2026 04 20; 23(1). Reed GE, McMahan VM, Chang YG, Johnson NL, Walley AY, Coffin PO, Harris MTH. PMID: 42010666; PMCID: PMC13227638.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Cardiovascular Conditions and Symptoms in Deaths Attributed to Acute Stimulant Toxicity. Circ Popul Health Outcomes. 2026 Apr; 19(4):e012683. Coffin PO, McMahan VM, Chang YG, Luna Marti X, Antolin Muñiz M, Chang JS, Knoll J, Rodda LN. PMID: 41889368; PMCID: PMC13035176.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Safety of Intravenous Methamphetamine in Patients Taking Mirtazapine: A Two-Site Phase 1b Randomized Controlled Trial. J Clin Psychopharmacol. 2026 Jul-Aug 01; 46(4):404-411. Black F, Santos GM, McMahan VM, Fraser A, Clark J, Sturgeon L, Walker J, Kochanska M, Shoptaw S, Coffin PO. PMID: 41779519; PMCID: PMC13229006.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    9. Sociodemographic and clinical factors associated with jail entry after a mental health crisis. Int J Law Psychiatry. 2026 May-Jun; 106:102205. Odes R, Myers J, Murnane PM, McDaniel M, Manjanatha D, Santos GM, Coffin PO, Goldman ML. PMID: 41785542.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Mechanisms of overdose from unintentional fentanyl use when intending to use stimulants: a qualitative study of people who use stimulants and avoid opioids. Res Sq. 2026 Feb 17. Gomez BO, Samayoa EY, Coffin PO, Suen LW, Ivey SL, Knight KR, McCuistian C, Appa A, Bazazi AR. PMID: 41756419; PMCID: PMC12934905.
      View in: PubMed   Mentions:
    11. A Comparison of Opioid Overdose Risk Behaviors by Race and Ethnicity Among Overdose Survivors in Boston, MA, and San Francisco, CA. Res Sq. 2026 Feb 13. Reed GE, McMahan VM, Chang YG, Johnson NL, Walley AY, Coffin PO, Harris MT. PMID: 41727581; PMCID: PMC12919185.
      View in: PubMed   Mentions:
    12. Interest in Long-Acting PrEP by Methamphetamine Use Among Men Who Have Sex with Men in Four Western US Cities. AIDS Behav. 2026 Feb 12. McMahan VM, Moreno C, Al-Tayyib A, Ma Y, McFarland W, Sey EK, Wilson EC, Liu AY, Coffin PO, Glick SN. PMID: 41678009; PMCID: PMC13098542.
      View in: PubMed   Mentions:    Fields:    
    13. Antecedents of Fentanyl Coinvolvement in Deaths Attributed to Stimulant Poisoning in San Francisco, CA. J Addict Med. 2026 Feb 10. Chang YG, McMahan VM, Rodda LN, Antolin Muñiz M, Brennan S, Luna Marti X, Lutz SM, Knoll J, Coffin PO. PMID: 41664290; PMCID: PMC13101575.
      View in: PubMed   Mentions:    Fields:    
    14. "It's like scratching at the door": Experiences of outpatient buprenorphine low dose initiation among people using fentanyl. J Subst Use Addict Treat. 2026 May; 184:209893. Suen LW, Samayoa E, Spinelli MA, Scarpetta M, Knight KR, Chael J, Soran CS, Geier M, Snyder HR, Coffin PO. PMID: 41610958.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV. Addict Sci Clin Pract. 2025 Dec 15; 21(1):7. Appa A, Marti XL, Baral S, Shoptaw S, Bazazi AR, Spinelli MA, Glidden D, Gandhi M, Coffin P. PMID: 41398703; PMCID: PMC12805729.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    16. A qualitative study exploring motivations for participating in research among women who use opioids. PLoS One. 2025; 20(11):e0336061. Bagley SM, Maschke AD, Harris MTH, Walley AY, Johnson S, Hurstak E, Farley J, Keller SG, McMahan VM, Barrett C, Coffin PO, Gunn CM. PMID: 41264582; PMCID: PMC12633877.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Repeated-dose behavioral intervention to reduce opioid overdose among overdose survivors with opioid use disorder: A two-site phase III randomized controlled trial. Addiction. 2026 Mar; 121(3):643-654. Coffin PO, Santos GM, McMahan VM, Luna Marti X, Matheson T, Brennan S, Arenander J, Robinson M, Farley J, Pope E, Rolles A, Kosakowski S, Green TC, Walley AY. PMID: 41261059.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    18. Witnessed overdose history and response among overdose survivors who use non-prescribed opioids in an overdose prevention trial. Addict Behav. 2026 Feb; 173:108558. McCann NC, Yan S, McMahan VM, Rich ZC, Pope E, Rolles A, Brennan S, Marti XL, Kosakowski S, Matheson T, Coffin PO, Walley AY. PMID: 41237599; PMCID: PMC12751120.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    19. Refining cause of death attribution among opioid, opioid-stimulant and stimulant acute toxicity deaths. Addiction. 2026 Feb; 121(2):288-294. Chang YG, Anderson N, Long K, Murphy C, McMahan VM, Rodda LN, Kral AH, Coffin PO. PMID: 40958719.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks. BMJ Open. 2025 Aug 24; 15(8):e100775. Mehtani NJ, Anderson BT, Alexander I, Hendricks PS, Mitchell JM, Coffin PO, Johnson MO. PMID: 40850924; PMCID: PMC12382537.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    21. Harm Reduction Contingency Management for Stimulant Use Reduction and Antiretroviral Therapy Adherence in HIV Primary Care: Protocol for an Implementation Effectiveness Study. JMIR Res Protoc. 2025 08 18; 14:e67292. Steiner G, Baral S, Riley ED, Shoptaw S, Chamie G, Roberts K, Suchman L, Knight K, Gandhi M, Coffin P, Appa A. PMID: 40825537; PMCID: PMC12402737.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    22. Neurological Injury and Outcomes in Fentanyl-related Cardiac Arrest. J Addict Med. 2026 May-Jun 01; 20(3):359-366. Otero M, Shih J, Zhou B, Ghandi S, Talbott J, Singhal NS, Calabrese E, Randazzo D, Coffin PO, Hemphill Iii JC, Amorim E. PMID: 40747898.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Early Change in Depressive Symptom Severity With Naltrexone-Bupropion Combination and Its Association With Reduction in Methamphetamine Use in ADAPT-2 Trial. J Clin Psychiatry. 2025 07 30; 86(3). Jha MK, Ghitza UE, Shoptaw S, Minhajuddin A, Kuruvila S, Wakhlu S, Nunes EV, Schmitz J, Coffin PO, Bart G, Carmody T, Trivedi MH. PMID: 40767786; PMCID: PMC12798894.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. The Association of Perceived Risk for Opioid Overdose and Subsequent Overdose Among a Cohort of Opioid Overdose Survivors Who Use Nonprescribed Opioids. Subst Use Addctn J. 2026 01; 47(1):153-158. Chang YG, McMahan VM, Matheson T, Luna Marti X, Robinson M, Rolles A, Kosakowski S, Santos GM, Walley AY, Coffin PO. PMID: 40698403; PMCID: PMC13055411.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Craving, Impulsivity, and Subsequent Methamphetamine Use With Naltrexone-Bupropion Versus Placebo: Findings From a Randomized Clinical Trial. J Addict Med. 2026 Mar-Apr 01; 20(2):214-222. Jha MK, Ghitza UE, Carmody T, Kuruvila S, Shoptaw S, Minhajuddin A, Wakhlu S, Schmitz JM, Coffin PO, Bart G, Nunes EV, Kenny P, Trivedi MH. PMID: 40623319; PMCID: PMC12798895.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Mirtazapine reduces hypothetical methamphetamine demand in humans. Drug Alcohol Depend. 2025 09 01; 274:112769. Rush CR, Santos GM, McMahan VM, Fraser A, Clark J, Luna Marti X, Walker JE, Shoptaw S, Coffin PO. PMID: 40580890; PMCID: PMC12279006.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Emergency medical system response, emergency department visits, and hospital admissions in response to non-fatal opioid overdoses reported by a cohort of overdose survivors in San Francisco and Boston, 2019 - 2022. Drug Alcohol Depend Rep. 2025 Sep; 16:100351. Smith RJ, McMahan VM, McCann NC, Kosakowski S, Brennan S, Marti XL, Walley AY, Coffin PO. PMID: 40606798; PMCID: PMC12219355.
      View in: PubMed   Mentions:
    28. Everything in moderation, even naloxone. Addiction. 2025 Nov; 120(11):2173-2174. Coffin PO. PMID: 40395073.
      View in: PubMed   Mentions: 1     Fields:    
    29. Interest in Long-Acting Preexposure Prophylaxis (PrEP) Among Men at Risk for Human Immunodeficiency Virus Who Use Methamphetamine Participating in a Daily, Oral PrEP Adherence Trial in San Francisco, California. Open Forum Infect Dis. 2025 May; 12(5):ofaf280. McMahan VM, Pope E, Luna Marti X, Walker J, Liu AY, Coffin PO. PMID: 40406373; PMCID: PMC12096071.
      View in: PubMed   Mentions:
    30. Thematic analysis of medical examiner narratives to understand the socio-spatial context, recency of drug use, and likely mechanism of stimulant toxicity deaths. Drug Alcohol Depend. 2025 Jul 01; 272:112700. Black F, McMahan VM, Chang YG, Rodda LN, Coffin PO. PMID: 40328078; PMCID: PMC12135998.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Barriers to Buprenorphine Treatment Among People Experiencing Homelessness: A Qualitative Study from the Provider Perspective. J Urban Health. 2025 Apr; 102(2):465-475. Masson CL, Knight KR, Levine EA, Spillane JA, Liang YCA, Suen LW, Chen MM, Zevin B, Schwartz RP, Coffin PO, Sorensen JL. PMID: 40148731; PMCID: PMC12031702.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Unintentional Fentanyl Use Detected in Hair of People With HIV Risk Using Methamphetamine. JAMA. 2025 Feb 26. Appa A, Spinelli MA, Javanbakht M, Heise MJ, Okochi H, Bazazi AR, Coffin P, Gorbach PM, Gandhi M. PMID: 40009421; PMCID: PMC11866066.
      View in: PubMed   Mentions:    Fields:    
    33. Test-Retest Reliability of a Timeline Follow-back Method to Assess Opioid Use and Treatment. J Addict Med. 2025 Sep-Oct 01; 19(5):565-569. McCann NC, Yan S, McMahan VM, Pope E, Rolles A, Brennan S, Marti XL, Kosakowski S, Coffin PO, Walley AY. PMID: 39908533; PMCID: PMC12233312.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. Prescribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal Landscape. J Addict Med. 2025 Jul-Aug 01; 19(4):347-349. Suen LW, Coffin PO, Boulton KE, Carr DH, Davis CS. PMID: 39846466; PMCID: PMC13274479.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    35. Addressing Methamphetamine Use Is Essential to Stopping HIV Transmission. J Acquir Immune Defic Syndr. 2025 Feb 01; 98(2):e9-e10. Black F, McMahan V, Luna Marti X, Pope E, Walker J, Liu A, Coffin PO. PMID: 39374037; PMCID: PMC11804937.
      View in: PubMed   Mentions: 2     Fields:    
    36. Identification of Behavioral, Clinical, and Psychological Antecedents of Acute Stimulant Poisoning: Development and Implementation of a Mixed Methods Psychological Autopsy Study. JMIR Form Res. 2025 01 13; 9:e64873. Antolin Muñiz M, McMahan VM, Luna Marti X, Brennan S, Tavasieff S, Rodda LN, Knoll J, Coffin PO. PMID: 39815401; PMCID: PMC11745507.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl. JAMA Netw Open. 2025 01 02; 8(1):e2456253. Suen LW, Chiang AY, Jones BLH, Soran CS, Geier M, Snyder HR, Neuhaus J, Myers JJ, Knight KR, Bazazi AR, Coffin PO. PMID: 39853975; PMCID: PMC11762237.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    38. Commentary on Stam et al.: The substantial and dynamic contribution of opioid potency to total overdose risk. Addiction. 2025 Feb; 120(2):293-295. Coffin PO. PMID: 39689973.
      View in: PubMed   Mentions:    Fields:    
    39. "They made me feel like I mattered": a qualitative study of how mobile crisis teams can support people experiencing homelessness. BMC Public Health. 2024 08 12; 24(1):2183. McDaniel M, Sundaram S, Manjanatha D, Odes R, Lerman P, Handley MA, Coffin PO, Myers JJ, Goldman ML. PMID: 39135047; PMCID: PMC11320767.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    40. Evaluation of methamphetamine assist packs: As-needed antipsychotics for self-management of methamphetamine-associated psychiatric toxicity. Int J Drug Policy. 2024 07; 129:104480. Coffin PO, Chang YG, McDaniel M, Leary M, Pating D, McMahan VM, Goldman ML. PMID: 38861841; PMCID: PMC11305928.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study. Harm Reduct J. 2024 04 09; 21(1):80. Jones BLH, Geier M, Neuhaus J, Coffin PO, Snyder HR, Soran CS, Knight KR, Suen LW. PMID: 38594721; PMCID: PMC11005253.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    42. Overdose from Unintentional Fentanyl Use when Intending to Use a Non-opioid Substance: An Analysis of Medically Attended Opioid Overdose Events. J Urban Health. 2024 04; 101(2):245-251. Bazazi AR, Low P, Gomez BO, Snyder H, Hom JK, Soran CS, Zevin B, Mason M, Graterol J, Coffin PO. PMID: 38568466; PMCID: PMC11052958.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    43. Brief Report: The Role of Substance Use in Structural Heart Disease Among Women Living With HIV. J Acquir Immune Defic Syndr. 2024 04 01; 95(4):342-346. Riley ED, Vittinghoff E, Ravi A, Coffin PO, Lynch KL, Wu AHB, Martinez C, Hsue PY. PMID: 38133589; PMCID: PMC10922783.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. Perception and Correlates of Opioid Overdose Risk Among Overdose Survivors Who Use Nonprescribed Opioids in San Francisco and Boston. Subst Use Addctn J. 2024 10; 45(4):559-567. Chang YG, McMahan VM, Marti XL, Pope E, Wolfe S, Majeski A, Reed G, Walley AY, Coffin PO. PMID: 38456483; PMCID: PMC11588015.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Stimulant use and opioid-related harm in patients on long-term opioids for chronic pain. Drug Alcohol Depend. 2024 03 01; 256:111065. Appa A, McMahan VM, Long K, Shade SB, Coffin PO. PMID: 38245963; PMCID: PMC10999379.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    46. The IMPACT (Infection Management Plus Addiction Care Together) Pilot: A Case Series of Combined Contingency Management for Substance Use Disorders and Antibiotic Adherence in the Hospital Setting. J Addict Med. 2024 Mar-Apr 01; 18(2):138-143. Appa A, Baral S, Stein B, Knight K, Gandhi M, Coffin P, Martin M. PMID: 38109334; PMCID: PMC10939948.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    47. Impact of San Francisco's New Street crisis response Team on Service use among people experiencing homelessness with mental and substance use disorders: A mixed methods study protocol. PLoS One. 2023; 18(12):e0295178. Goldman ML, McDaniel M, Manjanatha D, Rose ML, Santos GM, Shade SB, Lazar AA, Myers JJ, Handley MA, Coffin PO. PMID: 38051726; PMCID: PMC10697604.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Methamphetamine Toxicities and Clinical Management. NEJM Evid. 2023 12; 2(12):EVIDra2300160. Coffin PO, Suen LW. PMID: 38320504; PMCID: PMC11458184.
      View in: PubMed   Mentions: 8     Fields:    
    49. "If you're strung out and female, they will take advantage of you": A qualitative study exploring drug use and substance use service experiences among women in Boston and San Francisco. J Subst Use Addict Treat. 2024 02; 157:209190. Harris MTH, Laks J, Hurstak E, Jain JP, Lambert AM, Maschke AD, Bagley SM, Farley J, Coffin PO, McMahan VM, Barrett C, Walley AY, Gunn CM. PMID: 37866442; PMCID: PMC11040599.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    50. Cocaine Use is Associated With Increased LVMI in Unstably Housed Women With Polysubstance Use. Subst Abus. 2023 10; 44(4):323-329. Ravi A, Vittinghoff E, Wu AHB, Suen LW, Coffin PO, Hsue P, Lynch KL, Win S, Kazi DS, Riley ED. PMID: 37830512; PMCID: PMC11131938.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Feasibility and acceptability of a timeline follow-back method to assess opioid use, non-fatal overdose, and substance use disorder treatment. Addict Behav. 2024 01; 148:107873. McCann NC, McMahan VM, Smith R, Majeski A, Johns SL, Kosakowski S, Wolfe S, Brennan S, Robinson M, Coffin PO, Walley AY. PMID: 37801804; PMCID: PMC10618957.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    52. Sexual orientation differences among men in a randomized clinical trial of extended-release naltrexone and bupropion for methamphetamine use disorder. Drug Alcohol Depend. 2023 09 01; 250:110899. Kidd JD, Smiley SL, Coffin PO, Carmody TJ, Levin FR, Nunes EV, Shoptaw SJ, Trivedi MH. PMID: 37478502; PMCID: PMC10530262.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    53. Corrigendum to Surviving traumatic injury, only to die of acute drug poisoning: Should trauma centers be a path for intervention? [Surgery 170 (2021) pp 1249-54]. Surgery. 2023 Aug; 174(2):432. Bongiovanni T, Hernandez S, Ledesma Y, Menza R, Wick E, Steinman M, Mackersie R, Stein DM, Coffin PO. PMID: 37277307.
      View in: PubMed   Mentions:    Fields:    
    54. Multiple substance use and blood pressure in women experiencing homelessness. Addict Behav Rep. 2023 Jun; 17:100483. Suen LW, Vittinghoff E, Wu AHB, Ravi A, Coffin PO, Hsue P, Lynch KL, Kazi DS, Riley ED. PMID: 36875801; PMCID: PMC9975611.
      View in: PubMed   Mentions: 2  
    55. Primary care management of Long-Term opioid therapy. Ann Med. 2022 12; 54(1):2451-2469. Coffin PO, Martinez RS, Wylie B, Ryder B. PMID: 36111417; PMCID: PMC9487960.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    56. Implementation of a Leave-behind Naloxone Program in San Francisco: A One-year Experience. West J Emerg Med. 2022 Oct 31; 23(6):952-957. LeSaint KT, Montoy JCC, Silverman EC, Raven MC, Schow SL, Coffin PO, Brown JF, Mercer MP. PMID: 36409939; PMCID: PMC9683755.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    57. Targeted Oral Naltrexone for Mild to Moderate Alcohol Use Disorder Among Sexual and Gender Minority Men: A Randomized Trial. Am J Psychiatry. 2022 12 01; 179(12):915-926. Santos GM, Ikeda J, Coffin P, Walker J, Matheson T, Ali A, McLaughlin M, Jain J, Arenander J, Vittinghoff E, Batki S. PMID: 36285404; PMCID: PMC10072332.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    58. Impact of multiple substance use on circulating ST2, a biomarker of adverse cardiac remodelling, in women. Biomarkers. 2022 Dec; 27(8):802-808. Riley ED, Kazi DS, Coffin PO, Vittinghoff E, Wade AN, Bulfone TC, Lynch KL, Atai Z, Wu AHB. PMID: 36168954; PMCID: PMC9744090.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    59. Evidence of Pre-mortem Opioid Use among Fentanyl Overdose Decedents in a Safety Net Healthcare System. J Urban Health. 2022 10; 99(5):865-872. Coffin PO, McMahan VM, Murphy C. PMID: 35879486; PMCID: PMC9561460.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    60. "There's No Heroin Around Anymore. It's All Fentanyl." Adaptation of an Opioid Overdose Prevention Counseling Approach to Address Fentanyl Overdose: Formative Study. JMIR Form Res. 2022 Sep 07; 6(9):e37483. McMahan VM, Arenander J, Matheson T, Lambert AM, Brennan S, Green TC, Walley AY, Coffin PO. PMID: 36069781; PMCID: PMC9494212.
      View in: PubMed   Mentions: 12     Fields:    
    61. Multiple substance use, inflammation and cardiac stretch in women living with HIV. Drug Alcohol Depend. 2022 09 01; 238:109564. Riley ED, Kizer JR, Tien PC, Vittinghoff E, Lynch KL, Wu AHB, Coffin PO, Beck-Engeser G, Braun C, Hunt PW. PMID: 35872529; PMCID: PMC9924802.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Correlates of high phosphatidylethanol (PEth) levels and their concordance with self-reported heavy alcohol consumption among men who have sex with men who binge drink alcohol. Alcohol Clin Exp Res. 2022 08; 46(8):1565-1579. McLaughlin MF, Jain JP, Ikeda J, Walker JE, Coffin P, Santos GM. PMID: 35722862; PMCID: PMC10079307.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    63. A Chronic Condition Disguised as an Acute Event: the Case for Re-thinking Stimulant Overdose Death. J Gen Intern Med. 2022 10; 37(13):3462-3464. Riley ED, Hsue PY, Coffin PO. PMID: 35713806; PMCID: PMC9550944.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    64. Methadone treatment and patient-directed hospital discharges among patients with opioid use disorder: Observations from general medicine services at an urban, safety-net hospital. Drug Alcohol Depend Rep. 2022 Jun; 3:100066. Tierney HR, Rowe CL, Coffa DA, Sarnaik S, Coffin PO, Snyder HR. PMID: 36845982; PMCID: PMC9949313.
      View in: PubMed   Mentions: 3  
    65. Modeling of overdose and naloxone distribution in the setting of fentanyl compared to heroin. Drug Alcohol Depend. 2022 07 01; 236:109478. Coffin PO, Maya S, Kahn JG. PMID: 35588609; PMCID: PMC9235402.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    66. Engagement in HIV care and viral suppression following changes in long-term opioid therapy for treatment for chronic pain. AIDS Behav. 2022 Oct; 26(10):3220-3230. Silvis J, Rowe CL, Dobbins S, Haq N, Vittinghoff E, McMahan VM, Appa A, Coffin PO. PMID: 35380287; PMCID: PMC11230622.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    67. Inpatient Opioid Use Disorder Treatment by Generalists is Associated With Linkage to Opioid Treatment Programs After Discharge. J Addict Med. 2022 Mar-Apr 01; 16(2):169-176. Tierney HR, Rowe CL, Coffa DA, Sarnaik S, Coffin PO, Snyder HR. PMID: 33813579; PMCID: PMC11624023.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    68. Inherited Patients Taking Opioids for Chronic Pain - Considerations for Primary Care. N Engl J Med. 2022 Feb 17; 386(7):611-613. Coffin PO, Barreveld AM. PMID: 35148038; PMCID: PMC9555806.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    69. Rapid Overlap Initiation Protocol Using Low Dose Buprenorphine for Opioid Use Disorder Treatment in an Outpatient Setting: A Case Series. J Addict Med. 2022 Sep-Oct 01; 16(5):534-540. Suen LW, Lee TG, Silva M, Walton P, Coffin PO, Geier M, Soran CS. PMID: 35149614; PMCID: PMC11006272.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    70. Emergency department visits and trends related to cocaine, psychostimulants, and opioids in the United States, 2008-2018. BMC Emerg Med. 2022 02 04; 22(1):19. Suen LW, Davy-Mendez T, LeSaint KT, Riley ED, Coffin PO. PMID: 35120449; PMCID: PMC8814795.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    71. Comparative 1-Year Outcomes of Invasive Staphylococcus aureus Infections Among Persons With and Without Drug Use: An Observational Cohort Study. Clin Infect Dis. 2022 01 29; 74(2):263-270. Appa A, Adamo M, Le S, Davis J, Winston L, Doernberg SB, Chambers H, Martin M, Hills NK, Coffin PO, Jain V. PMID: 33904900; PMCID: PMC8800187.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    72. Factors Associated with Pain Treatment Satisfaction Among Patients with Chronic Non-Cancer Pain and Substance Use. J Am Board Fam Med. 2021 Nov-Dec; 34(6):1082-1095. Suen LW, McMahan VM, Rowe C, Bhardwaj S, Knight K, Kushel MB, Santos GM, Coffin P. PMID: 34772764; PMCID: PMC8813175.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    73. Non-fatal stimulant overdose among homeless and unstably housed women in San Francisco, California. Drug Alcohol Depend. 2021 11 01; 228:109085. Davy-Mendez T, Vittinghoff E, Dilworth SE, Suen LW, Braun C, Coffin PO, Satre DD, Riley ED. PMID: 34600248; PMCID: PMC8595709.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    74. Patient-Directed Discharges Among Persons Who Use Drugs Hospitalized with Invasive Staphylococcus aureus Infections: Opportunities for Improvement. Am J Med. 2022 01; 135(1):91-96. Appa A, Adamo M, Le S, Davis J, Winston L, Doernberg SB, Chambers H, Martin M, Hills NK, Coffin P, Jain V. PMID: 34508704; PMCID: PMC11552656.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    75. Pilot study of extended-release lorcaserin for cocaine use disorder among men who have sex with men: A double-blind, placebo-controlled randomized trial. PLoS One. 2021; 16(7):e0254724. Santos GM, Ikeda J, Coffin P, Walker JE, Matheson T, McLaughlin M, Jain J, Vittinghoff E, Batki SL. PMID: 34265007; PMCID: PMC8282062.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    76. Evaluating the Effects of Opioid Prescribing Policies on Patient Outcomes in a Safety-net Primary Care Clinic. J Gen Intern Med. 2022 01; 37(1):117-124. Rowe CL, Eagen K, Ahern J, Faul M, Hubbard A, Coffin P. PMID: 34173204; PMCID: PMC8738839.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    77. Drug Overdose Deaths Before and After Shelter-in-Place Orders During the COVID-19 Pandemic in San Francisco. JAMA Netw Open. 2021 May 03; 4(5):e2110452. Appa A, Rodda LN, Cawley C, Zevin B, Coffin PO, Gandhi M, Imbert E. PMID: 33978726; PMCID: PMC8116981.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCellsPHPublic Health
    78. Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program. J Subst Abuse Treat. 2022 01; 132:108452. Rowe CL, Ahern J, Hubbard A, Coffin PO. PMID: 34098203; PMCID: PMC10023135.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    79. Surviving traumatic injury, only to die of acute drug poisoning: Should trauma centers be a path for intervention? Surgery. 2021 10; 170(4):1249-1254. Bongiovanni T, Hernandez S, Ledesma Y, Menza R, Wick E, Steinman M, Mackersie R, Stein DM, Coffin PO. PMID: 33867166; PMCID: PMC11637652.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    80. Stimulant use for self-management of pain among safety-net patients with chronic non-cancer pain. Subst Abus. 2022; 43(1):179-186. Beliveau CM, McMahan VM, Arenander J, Angst MS, Kushel M, Torres A, Santos GM, Coffin PO. PMID: 33798030; PMCID: PMC8791072.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    81. Race, pain, and opioids among patients with chronic pain in a safety-net health system. Drug Alcohol Depend. 2021 05 01; 222:108671. Haq N, McMahan VM, Torres A, Santos GM, Knight K, Kushel M, Coffin PO. PMID: 33810908; PMCID: PMC8687128.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    82. Using ICD-10-CM codes to detect illicit substance use: A comparison with retrospective self-report. Drug Alcohol Depend. 2021 04 01; 221:108537. Rowe CL, Santos GM, Kornbluh W, Bhardwaj S, Faul M, Coffin PO. PMID: 33621806; PMCID: PMC11008535.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    83. Bupropion and Naltrexone in Methamphetamine Use Disorder. N Engl J Med. 2021 01 14; 384(2):140-153. Trivedi MH, Walker R, Ling W, Dela Cruz A, Sharma G, Carmody T, Ghitza UE, Wahle A, Kim M, Shores-Wilson K, Sparenborg S, Coffin P, Schmitz J, Wiest K, Bart G, Sonne SC, Wakhlu S, Rush AJ, Nunes EV, Shoptaw S. PMID: 33497547; PMCID: PMC8111570.
      View in: PubMed   Mentions: 123     Fields:    Translation:Humans
    84. Unsafe Injection Is Associated with Higher HIV Testing after Bayesian Adjustment for Unmeasured Confounding. Arch Iran Med. 2020 12 01; 23(12):848-855. Navadeh S, Mirzazadeh A, McFarland W, Coffin P, Chehrazi M, Mohammad K, Nazemipour M, Mansournia MA, McCandless LC, Page K. PMID: 33356343; PMCID: PMC9844981.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    85. Beyond Overdose: Drug-Related Deaths in People With and Without HIV in San Francisco, 2007-2018. Open Forum Infect Dis. 2020 Dec; 7(12):ofaa565. Appa A, Rowe C, Hessol NA, Coffin P. PMID: 33409331; PMCID: PMC7757430.
      View in: PubMed   Mentions: 1  
    86. Impact of polysubstance use on high-sensitivity cardiac troponin I over time in homeless and unstably housed women. Drug Alcohol Depend. 2020 12 01; 217:108252. Riley ED, Vittinghoff E, Wu AHB, Coffin PO, Hsue PY, Kazi DS, Wade A, Braun C, Lynch KL. PMID: 32919207; PMCID: PMC7873814.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    87. Illicit opioid use following changes in opioids prescribed for chronic non-cancer pain. PLoS One. 2020; 15(5):e0232538. Coffin PO, Rowe C, Oman N, Sinchek K, Santos GM, Faul M, Bagnulo R, Mohamed D, Vittinghoff E. PMID: 32365132; PMCID: PMC7197848.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    88. "Chasing the pain relief, not the high": Experiences managing pain after opioid reductions among patients with HIV and a history of substance use. PLoS One. 2020; 15(3):e0230408. Behar E, Bagnulo R, Knight K, Santos GM, Coffin PO. PMID: 32210442; PMCID: PMC7094831.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    89. Addressing overdose risk among unstably housed women in San Francisco, California: an examination of potential fentanyl contamination of multiple substances. Harm Reduct J. 2020 03 10; 17(1):17. Meacham MC, Lynch KL, Coffin PO, Wade A, Wheeler E, Riley ED. PMID: 32156289; PMCID: PMC7063812.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    90. Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial. JAMA Psychiatry. 2020 03 01; 77(3):246-255. Coffin PO, Santos GM, Hern J, Vittinghoff E, Walker JE, Matheson T, Santos D, Colfax G, Batki SL. PMID: 31825466; PMCID: PMC6990973.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    91. Overdose Education and Naloxone Distribution in the San Francisco County Jail. J Correct Health Care. 2019 10; 25(4):394-404. Wenger LD, Showalter D, Lambdin B, Leiva D, Wheeler E, Davidson PJ, Coffin PO, Binswanger IA, Kral AH. PMID: 31672075.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    92. Drug overdose mortality among residents of single room occupancy buildings in San Francisco, California, 2010-2017. Drug Alcohol Depend. 2019 11 01; 204:107571. Rowe CL, Riley ED, Eagen K, Zevin B, Coffin PO. PMID: 31581024; PMCID: PMC11105971.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    93. Narratives of people who inject drugs on factors contributing to opioid overdose. Int J Drug Policy. 2019 12; 74:26-32. Chang JS, Behar E, Coffin PO. PMID: 31442677; PMCID: PMC11702908.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    94. Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs. PLoS One. 2019; 14(6):e0217471. Coffin PO, Santos GM, Behar E, Hern J, Walker J, Matheson T, Kinnard EN, Silvis J, Vittinghoff E, Fox R, Page K. PMID: 31158245; PMCID: PMC6546233.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    95. Perceived Causes of Personal versus Witnessed Overdoses among People who Inject Opioids. Subst Use Misuse. 2019; 54(12):1929-1937. Behar E, Chang JS, Countess K, Matheson T, Santos GM, Coffin P. PMID: 31070106; PMCID: PMC7185847.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    96. Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated. Drug Alcohol Depend. 2019 05 01; 198:133-135. Morris MD, Mirzazadeh A, Evans JL, Briceno A, Coffin P, Hahn JA, Page KA. PMID: 30921649; PMCID: PMC6482851.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    97. CT Attenuation of Acute Subdural Hematomas in Patients with Anemia. J Neuroimaging. 2019 07; 29(4):536-539. Duy L, Badeeb A, Duy W, Alqahtani E, Champion W, Kim DH, Martin D, Vartanians V, Coffin P, Small JE. PMID: 30771278.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    98. Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015. J Urban Health. 2019 02; 96(1):6-11. Rowe C, Wheeler E, Stephen Jones T, Yeh C, Coffin PO. PMID: 29725887; PMCID: PMC6391290.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    99. Overdose Research: 15 Years Later. J Urban Health. 2019 02; 96(1):1-5. Coffin PO, Rich JD. PMID: 30623291; PMCID: PMC6391289.
      View in: PubMed   Mentions:    Fields:    
    100. Acceptability of Naloxone Dispensing Among Pharmacists. J Pharm Pract. 2020 Jun; 33(3):247-254. Do V, Behar E, Turner C, Geier M, Coffin P. PMID: 30180774; PMCID: PMC6756989.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    101. Prevalence and correlates of hazardous alcohol consumption and binge drinking among men who have sex with men (MSM) in San Francisco. PLoS One. 2018; 13(8):e0202170. Santos GM, Rowe C, Hern J, Walker JE, Ali A, Ornelaz M, Prescott M, Coffin P, McFarland W, Raymond HF. PMID: 30118495; PMCID: PMC6097698.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    102. Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review. Prev Med. 2018 09; 114:79-87. Behar E, Bagnulo R, Coffin PO. PMID: 29908763; PMCID: PMC6082708.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    103. Accuracy of HIV Risk Perceptions Among Episodic Substance-Using Men Who Have Sex with Men. AIDS Behav. 2018 Jun; 22(6):1932-1943. Hall GC, Koenig LJ, Gray SC, Herbst JH, Matheson T, Coffin P, Raiford J. PMID: 29103191.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    104. Quantity fluctuations of illicitly used opioids and overdose risk. Int J Drug Policy. 2018 08; 58:64-70. Rowe C, Wheeler E, Vittinghoff E, Santos GM, Behar E, Coffin PO. PMID: 29807248; PMCID: PMC6419728.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    105. Cross-sectional cause of death comparisons for stimulant and opioid mortality in San Francisco, 2005-2015. Drug Alcohol Depend. 2018 04 01; 185:305-312. Turner C, Chandrakumar D, Rowe C, Santos GM, Riley ED, Coffin PO. PMID: 29486419; PMCID: PMC6474784.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    106. Correlates of Validity of Self-Reported Methamphetamine Use among a Sample of Dependent Adults. Subst Use Misuse. 2018 08 24; 53(10):1742-1755. Rowe C, Vittinghoff E, Colfax G, Coffin PO, Santos GM. PMID: 29461134; PMCID: PMC6530983.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    107. Impacts of an opioid overdose prevention intervention delivered subsequent to acute care. Inj Prev. 2019 06; 25(3):191-198. Banta-Green CJ, Coffin PO, Merrill JO, Sears JM, Dunn C, Floyd AS, Whiteside LK, Yanez ND, Donovan DM. PMID: 29436397; PMCID: PMC6800078.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    108. Using medical examiner case narratives to improve opioid overdose surveillance. Int J Drug Policy. 2018 04; 54:35-42. Hurstak E, Rowe C, Turner C, Behar E, Cabugao R, Lemos NP, Burke C, Coffin P. PMID: 29353022; PMCID: PMC5899632.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    109. Management of Suspected Opioid Overdose With Naloxone in Out-of-Hospital Settings: A Systematic Review. Ann Intern Med. 2017 Dec 19; 167(12):867-875. Chou R, Korthuis PT, McCarty D, Coffin PO, Griffin JC, Davis-O'Reilly C, Grusing S, Daya M. PMID: 29181532.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    110. Low-threshold extended-release naltrexone for high utilizers of public services with severe alcohol use disorder: A pilot study. J Subst Abuse Treat. 2018 02; 85:109-115. Smith-Bernardin S, Rowe C, Behar E, Geier M, Washington S, Santos GM, Euren J, Martin J, Gleghorn A, Coffin PO. PMID: 29150316.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    111. Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel. 2017. Chou R, Korthuis PT, McCarty D, Coffin P, Griffin J, Davis-O’Reilly C, Grusing S, Daya M. View Publication.
    112. Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial. PLoS One. 2017; 12(10):e0183354. Coffin PO, Santos GM, Matheson T, Behar E, Rowe C, Rubin T, Silvis J, Vittinghoff E. PMID: 29049282; PMCID: PMC5648110.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    113. Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial. Addiction. 2018 02; 113(2):268-278. Coffin PO, Santos GM, Hern J, Vittinghoff E, Santos D, Matheson T, Colfax G, Batki SL. PMID: 28734107; PMCID: PMC5760469.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    114. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017 08; 46:172-179. Fairbairn N, Coffin PO, Walley AY. PMID: 28687187; PMCID: PMC5783633.
      View in: PubMed   Mentions: 133     Fields:    Translation:Humans
    115. New developments and opportunities for preventing hepatitis C virus (HCV) among people who use and inject drugs-announcing an Addiction series. Addiction. 2017 07; 112(7):1126-1127. Hickman M, Grebely J, Bruneau J, Coffin P, Degenhardt L, Hutchinson S, Larney S, Martin N, Treloar C, Vickerman P. PMID: 28586551.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    116. Heroin and pharmaceutical opioid overdose events: Emergency medical response characteristics. Drug Alcohol Depend. 2017 09 01; 178:1-6. Banta-Green CJ, Coffin PO, Schoeppe JA, Merrill JO, Whiteside LK, Ebersol AK. PMID: 28623805.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    117. Performance Measures of Diagnostic Codes for Detecting Opioid Overdose in the Emergency Department. Acad Emerg Med. 2017 Apr; 24(4):475-483. Rowe C, Vittinghoff E, Santos GM, Behar E, Turner C, Coffin PO. PMID: 27763703.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    118. Academic Detailing Pilot for Naloxone Prescribing Among Primary Care Providers in San Francisco. Fam Med. 2017 Feb; 49(2):122-126. Behar E, Rowe C, Santos GM, Santos N, Coffin PO. PMID: 28218937.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    119. Race/ethnicity, education, and age are associated with engagement in ecological momentary assessment text messaging among substance-using MSM in San Francisco. J Subst Abuse Treat. 2017 04; 75:43-48. Turner CM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Batki S, Santos GM. PMID: 28237053; PMCID: PMC5367385.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    120. Social mixing and correlates of injection frequency among opioid use partnerships. Int J Drug Policy. 2017 03; 41:80-88. Rowe C, Santos GM, Raymond HF, Coffin PO. PMID: 28113118.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    121. Higher prevalence of detectable troponin I among cocaine-users without known cardiovascular disease. Drug Alcohol Depend. 2017 Mar 01; 172:88-93. Riley ED, Hsue PY, Vittinghoff E, Wu AH, Coffin PO, Moore PK, Lynch KL. PMID: 28157591; PMCID: PMC5464776.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    122. Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs. Int J Drug Policy. 2017 Jan; 39:114-120. Walley AY, Cheng DM, Quinn EK, Blokhina E, Gnatienko N, Chaisson CE, Krupitsky E, Coffin PO, Samet JH. PMID: 27907848; PMCID: PMC5191979.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    123. Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for Pain. J Gen Intern Med. 2017 Mar; 32(3):291-295. Behar E, Rowe C, Santos GM, Coffa D, Turner C, Santos NC, Coffin PO. PMID: 27815762; PMCID: PMC5331006.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    124. Primary Care Patient Experience with Naloxone Prescription. Ann Fam Med. 2016 09; 14(5):431-6. Behar E, Rowe C, Santos GM, Murphy S, Coffin PO. PMID: 27621159; PMCID: PMC5394366.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    125. While we dither, people continue to die from overdose: Comments on 'Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?'. Addiction. 2016 10; 111(10):1880-1. Coffin P, Rich J, Dailey M, Stancliff S, Beletsky L. PMID: 27412566; PMCID: PMC5510754.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    126. Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain. Ann Intern Med. 2016 Aug 16; 165(4):245-52. Coffin PO, Behar E, Rowe C, Santos GM, Coffa D, Bald M, Vittinghoff E. PMID: 27366987; PMCID: PMC5783639.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCTClinical Trials
    127. Binge drinking concurrent with anal intercourse and condom use among men who have sex with men. AIDS Care. 2016 12; 28(12):1566-1570. Rowe C, Liou T, Vittinghoff E, Coffin PO, Santos GM. PMID: 27241085; PMCID: PMC5144827.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    128. Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men. J Acquir Immune Defic Syndr. 2016 May 01; 72(1):21-30. Santos GM, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Hahn JA, Vlahov D, Vittinghoff E, Batki SL. PMID: 26674372; PMCID: PMC4837026.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    129. Correlates of recent HIV testing among substance-using men who have sex with men. Int J STD AIDS. 2017 05; 28(6):594-601. Rowe C, Matheson T, Das M, DeMicco E, Herbst JH, Coffin PO, Santos GM. PMID: 27000299.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    130. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths. J Urban Health. 2016 Feb; 93(1):117-30. Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO. PMID: 26800987; PMCID: PMC4794468.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    131. Commentary on Pierce et al. (2016): Raising the bar of addiction treatment--first do no harm. Addiction. 2016 Feb; 111(2):309-10. Banta-Green CJ, Coffin PO. PMID: 26767339.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    132. Correlates of overdose risk perception among illicit opioid users. Drug Alcohol Depend. 2016 Feb 01; 159:234-9. Rowe C, Santos GM, Behar E, Coffin PO. PMID: 26754425; PMCID: PMC4734628.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    133. Regular clinic attendance in two large San Francisco HIV primary care settings. AIDS Care. 2016; 28(5):579-84. Cohen JK, Santos GM, Moss NJ, Coffin PO, Block N, Klausner JD. PMID: 26654093.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    134. Opioid Overdose Deaths in the City and County of San Francisco: Prevalence, Distribution, and Disparities. J Urban Health. 2015 Aug; 92(4):758-72. Visconti AJ, Santos GM, Lemos NP, Burke C, Coffin PO. PMID: 26077643; PMCID: PMC4524842.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    135. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program. Addiction. 2015 Aug; 110(8):1301-10. Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO. PMID: 25917125; PMCID: PMC4503489.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    136. Novel interventions to prevent HIV and HCV among persons who inject drugs. Curr HIV/AIDS Rep. 2015 Mar; 12(1):145-63. Coffin PO, Rowe C, Santos GM. PMID: 25589380.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    137. Brief overdose education is sufficient for naloxone distribution to opioid users. Drug Alcohol Depend. 2015 Mar 01; 148:209-12. Behar E, Santos GM, Wheeler E, Rowe C, Coffin PO. PMID: 25595053.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    138. Trends in use of health care and HIV prevention services for persons who inject drugs in San Francisco: results from National HIV Behavioral Surveillance 2005-2012. Drug Alcohol Depend. 2015 Jan 01; 146:45-51. Coffin PO, Jin H, Huriaux E, Mirzazadeh A, Raymond HF. PMID: 25468816.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    139. Intranasal Naloxone for Opioid Overdose Reversal. Prehosp Emerg Care. 2015 January-March; 19(1):135-137. Davis CS, Banta-Green CJ, Coffin P, Dailey MW, Walley AY. PMID: 25153260.
      View in: PubMed   Mentions: 1     Fields:    
    140. The dueling obligations of opioid stewardship. Ann Intern Med. 2014 Aug 19; 161(4):307-8. Coffin P, Banta-Green C. PMID: 25133372.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    141. Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses. Drug Alcohol Depend. 2014 Oct 01; 143:277-80. Hermanstyne KA, Santos GM, Vittinghoff E, Santos D, Colfax G, Coffin P. PMID: 25156227; PMCID: PMC4170077.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    142. Ending hepatitis C in the United States: the role of screening. Hepat Med. 2014; 6:79-87. Coffin PO, Reynolds A. PMID: 25114602; PMCID: PMC4086667.
      View in: PubMed   Mentions: 11  
    143. Adapted personalized cognitive counseling for episodic substance-using men who have sex with men: a randomized controlled trial. AIDS Behav. 2014 Jul; 18(7):1390-400. Coffin PO, Santos GM, Colfax G, Das M, Matheson T, DeMicco E, Dilley J, Vittinghoff E, Raiford JL, Carry M, Herbst JH. PMID: 24510401; PMCID: PMC4655874.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    144. Substance use and drinking outcomes in Personalized Cognitive Counseling randomized trial for episodic substance-using men who have sex with men. Drug Alcohol Depend. 2014 May 01; 138:234-9. Santos GM, Coffin PO, Vittinghoff E, DeMicco E, Das M, Matheson T, Raiford JL, Carry M, Colfax G, Herbst JH, Dilley JW. PMID: 24641808; PMCID: PMC4673670.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    145. The dueling obligations of opioid stewardship. Ann Intern Med. 2014 Feb 04; 160(3):207. Coffin P, Banta-Green C. PMID: 24322334.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    146. Police officers' and paramedics' experiences with overdose and their knowledge and opinions of Washington State's drug overdose-naloxone-Good Samaritan law. J Urban Health. 2013 Dec; 90(6):1102-11. Banta-Green CJ, Beletsky L, Schoeppe JA, Coffin PO, Kuszler PC. PMID: 23900788; PMCID: PMC3853169.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    147. Dose-response associations between number and frequency of substance use and high-risk sexual behaviors among HIV-negative substance-using men who have sex with men (SUMSM) in San Francisco. J Acquir Immune Defic Syndr. 2013 Aug 01; 63(4):540-4. Santos GM, Coffin PO, Das M, Matheson T, DeMicco E, Raiford JL, Vittinghoff E, Dilley JW, Colfax G, Herbst JH. PMID: 23572012; PMCID: PMC4671496.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    148. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities. J Med Econ. 2013 Aug; 16(8):1051-60. Coffin PO, Sullivan SD. PMID: 23730942.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    149. Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction. 2013 Apr; 108(4):751-61. Coffin PO, Santos GM, Das M, Santos DM, Huffaker S, Matheson T, Gasper J, Vittinghoff E, Colfax GN. PMID: 23186131; PMCID: PMC3602333.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    150. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013 Jan 01; 158(1):1-9. Coffin PO, Sullivan SD. PMID: 23277895.
      View in: PubMed   Mentions: 151     Fields:    Translation:Humans
    151. "Hooked on" prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients. J Psychoactive Drugs. 2012 Jul-Aug; 44(3):259-65. Peavy KM, Banta-Green CJ, Kingston S, Hanrahan M, Merrill JO, Coffin PO. PMID: 23061326.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    152. Prevalence and characteristics of femoral injection among Seattle-area injection drug users. J Urban Health. 2012 Apr; 89(2):365-72. Coffin PO, Coffin LS, Murphy S, Jenkins LM, Golden MR. PMID: 22391984; PMCID: PMC3324607.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    153. Cost-effectiveness and population outcomes of general population screening for hepatitis C. Clin Infect Dis. 2012 May; 54(9):1259-71. Coffin PO, Scott JD, Golden MR, Sullivan SD. PMID: 22412061; PMCID: PMC3404694.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCellsPHPublic Health
    154. Patient acceptance of universal screening for hepatitis C virus infection. BMC Infect Dis. 2011 Jun 06; 11:160. Coffin PO, Stevens AM, Scott JD, Stekler JD, Golden MR. PMID: 21645388; PMCID: PMC3118145.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsPHPublic Health
    155. Risk factors for nonfatal overdose at Seattle-area syringe exchanges. J Urban Health. 2011 Feb; 88(1):118-28. Jenkins LM, Banta-Green CJ, Maynard C, Kingston S, Hanrahan M, Merrill JO, Coffin PO. PMID: 21246299; PMCID: PMC3042084.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    156. The interface between substance abuse and chronic pain management in primary care: a curriculum for medical residents. Subst Abus. 2009 Jul-Sep; 30(3):253-60. Gunderson EW, Coffin PO, Chang N, Polydorou S, Levin FR. PMID: 19591063; PMCID: PMC2821184.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    157. Balancing the costs and benefits of opioid analgesics in the United States. Public Health. 2009 Feb; 123(2):147-8; discussion 149-50. Coffin PO. PMID: 19168193.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    158. Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med. 2007 Jul; 14(7):616-23. Coffin PO, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. PMID: 17554010.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansPHPublic Health
    159. Mortality after release from prison. N Engl J Med. 2007 Apr 26; 356(17):1785; author reply 1786-7. Coffin PO. PMID: 17465043.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    160. Cause of death in alcoholic hepatitis. J Hosp Med. 2007 Jan; 2(1):51-2. Coffin PO, Sharpe BA. PMID: 17295316.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    161. Safe syringe disposal is related to safe syringe access among HIV-positive injection drug users. AIDS Behav. 2007 Sep; 11(5):652-62. Coffin PO, Latka MH, Latkin C, Wu Y, Purcell DW, Metsch L, Gomez C, Gourevitch MN, INSPIRE Study Group. PMID: 17053854.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    162. Support for buprenorphine and methadone prescription to heroin-dependent patients among New York City physicians. Am J Drug Alcohol Abuse. 2006; 32(1):1-6. Coffin PO, Blaney S, Fuller C, Vadnai L, Miller S, Vlahov D. PMID: 16450639.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    163. Heroin and cocaine dependence and the risk of accidental non-fatal drug overdose. J Addict Dis. 2006; 25(3):79-87. Galea S, Nandi A, Coffin PO, Tracy M, Markham Piper T, Ompad D, Vlahov D. PMID: 16956872.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    164. Circumstances of witnessed drug overdose in New York City: implications for intervention. Drug Alcohol Depend. 2005 Aug 01; 79(2):181-90. Tracy M, Piper TM, Ompad D, Bucciarelli A, Coffin PO, Vlahov D, Galea S. PMID: 16002027.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    165. Integrating HIV risk reduction into the medical curriculum. Med Educ. 2004 Nov; 38(11):1197-8. Ciccarone D, Coffin P, Preer G. PMID: 15507033; PMCID: PMC2579263.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    166. Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City. Clin Infect Dis. 2004 Feb 01; 38(3):438-41. Coffin PO, Fuller C, Blaney S, Vadnai L, Miller S, Vlahov D. PMID: 14727219.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    167. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction. 2003 Jun; 98(6):739-47. Coffin PO, Galea S, Ahern J, Leon AC, Vlahov D, Tardiff K. PMID: 12780362.
      View in: PubMed   Mentions: 132     Fields:    Translation:Humans
    168. Drug overdose: new insights, innovative surveillance, and promising interventions. J Urban Health. 2003 Jun; 80(2):186-8. Galea S, Coffin PO. PMID: 12791794; PMCID: PMC3456278.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    169. Racial/ethnic disparities in overdose mortality trends in New York City, 1990-1998. J Urban Health. 2003 Jun; 80(2):201-11. Galea S, Ahern J, Tardiff K, Leon A, Coffin PO, Derr K, Vlahov D. PMID: 12791796; PMCID: PMC3456270.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    170. Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City. J Urban Health. 2003 Jun; 80(2):288-90. Coffin PO, Fuller C, Vadnai L, Blaney S, Galea S, Vlahov D. PMID: 12791804; PMCID: PMC3456271.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    171. Income distribution and risk of fatal drug overdose in New York City neighborhoods. Drug Alcohol Depend. 2003 May 21; 70(2):139-48. Galea S, Ahern J, Vlahov D, Coffin PO, Fuller C, Leon AC, Tardiff K. PMID: 12732407.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    172. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. J Am Pharm Assoc (Wash). 2002 Nov-Dec; 42(6 Suppl 2):S62-7. Coffin PO, Ahern J, Dorris S, Stevenson L, Fuller C, Vlahov D. PMID: 12489618.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    173. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc (Wash). 2002 Nov-Dec; 42(6 Suppl 2):S77-82. Fuller CM, Ahern J, Vadnai L, Coffin PO, Galea S, Factor SH, Vlahov D. PMID: 12489621.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansPHPublic Health
    174. Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal. J Am Pharm Assoc (Wash). 2002 Nov-Dec; 42(6 Suppl 2):S6-9. Jones TS, Coffin PO. PMID: 12489602.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    175. A vulnerable population in a time of crisis: drug users and the attacks on the World Trade Center. J Urban Health. 2002 Sep; 79(3):392-403. Weiss L, Fabri A, McCoy K, Coffin P, Netherland J, Finkelstein R. PMID: 12200508; PMCID: PMC3456778.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    176. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. J Urban Health. 2000 Dec; 77(4):781-93. Coffin PO, Linas BP, Factor SH, Vlahov D. PMID: 11194317; PMCID: PMC3456774.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    177. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation. J Urban Health. 2000 Dec; 77(4):768-80. Linas BP, Coffin PO, Backes G, Vlahov D. PMID: 11194316; PMCID: PMC3456767.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    178. Syringe availability as HIV prevention: a review of modalities. J Urban Health. 2000 Sep; 77(3):306-30. Coffin P. PMID: 10976607; PMCID: PMC3456039.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    179. Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Res. 1999 Mar 20; 822(1-2):237-42. Martin WJ, Coffin PO, Attias E, Balinsky M, Tsou K, Walker JM. PMID: 10082902.
      View in: PubMed   Mentions: 49     Fields:    Translation:AnimalsCells
    180. An examination of the central sites of action of cannabinoid-induced antinociception in the rat. Life Sci. 1995; 56(23-24):2103-9. Martin WJ, Patrick SL, Coffin PO, Tsou K, Walker JM. PMID: 7776838.
      View in: PubMed   Mentions: 56     Fields:    Translation:AnimalsCells
    Phillip's Networks
    Concepts (371)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (92)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.